Powder: -20°C for 3 years | In solvent: -80°C for 1 year
P7C3-OMe, a pro-neurogenic agent, has therapeutic benefits in neurodegenerative diseases. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 72.00 | |
2 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 155.00 | |
10 mg | In stock | $ 228.00 | |
25 mg | In stock | $ 463.00 | |
50 mg | In stock | $ 682.00 | |
100 mg | In stock | $ 969.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 173.00 |
Description | P7C3-OMe, a pro-neurogenic agent, has therapeutic benefits in neurodegenerative diseases. The R-enantiomer of P7C3-OMe is far more active than the S-enantiomer. |
Molecular Weight | 504.21 |
Formula | C22H20Br2N2O2 |
CAS No. | 313268-18-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (198.33 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
P7C3-OMe 313268-18-7 Others Inhibitor P7C3OMe P-7C3-OMe inhibit P7C3 OMe inhibitor